Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
PDS Biotechnology Corporation (NASDAQ: PDSB) closed the day trading at $3.54 down -1.53% from the previous closing price of $3.59. In other words, the price has decreased by -$1.53 from its previous closing price. On the day, 0.71 million shares were traded. PDSB stock price reached its highest trading level at $3.77 during the session, while it also had its lowest trading level at $3.485.
Ratios:
For a better understanding of PDSB, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.33 and its Current Ratio is at 4.33. In the meantime, Its Debt-to-Equity ratio is 0.91 whereas as Long-Term Debt/Eq ratio is at 0.75.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, B. Riley Securities on November 01, 2022, initiated with a Buy rating and assigned the stock a target price of $10.
On June 28, 2021, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $25.
H.C. Wainwright Upgraded its Neutral to Buy on November 10, 2020, while the target price for the stock was maintained at $6.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PDSB now has a Market Capitalization of 131678752 and an Enterprise Value of 96952336.
Stock Price History:
Over the past 52 weeks, PDSB has reached a high of $10.27, while it has fallen to a 52-week low of $2.59. The 50-Day Moving Average of the stock is -10.97%, while the 200-Day Moving Average is calculated to be -28.03%.
Shares Statistics:
Over the past 3-months, PDSB traded about 949.98K shares per day on average, while over the past 10 days, PDSB traded about 839390 shares per day. A total of 36.68M shares are outstanding, with a floating share count of 34.87M. Insiders hold about 4.94% of the company’s shares, while institutions hold 22.17% stake in the company. Shares short for PDSB as of 1714435200 were 6864020 with a Short Ratio of 7.23, compared to 1711584000 on 6152075. Therefore, it implies a Short% of Shares Outstanding of 6864020 and a Short% of Float of 19.36.
Earnings Estimates
The stock of PDS Biotechnology Corporation (PDSB) is currently in the spotlight, with 6.0 analysts actively rating and assessing its market standing.On average, analysts expect EPS of -$0.37 for the current quarter, with a high estimate of -$0.28 and a low estimate of -$0.45, while EPS last year was -$0.32. The consensus estimate for the next quarter is -$0.36, with high estimates of -$0.28 and low estimates of -$0.45.
Analysts are recommending an EPS of between -$1.11 and -$1.76 for the fiscal current year, implying an average EPS of -$1.51. EPS for the following year is -$1.61, with 5.0 analysts recommending between -$1.3 and -$1.97.
